Difference between revisions of "QIBA PET Amyloid Biomarker Committee Call Summaries"
Jump to navigation
Jump to search
(→2016) |
m (→2017) |
||
| (11 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
| + | ==2017== | ||
| + | |||
| + | *[[Media:09_08_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|09.08.2017 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
| + | |||
| + | *[[Media:08_11_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|08.11.2017 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
| + | |||
| + | *[[Media:07_14_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|07.14.2017 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
| + | |||
| + | *There are no notes for June, as this call was used for the Nuclear Medicine Coordinating Committee. | ||
| + | |||
| + | *[[Media:05_12_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|05.12.2017 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
| + | |||
| + | *[[Media:04_14_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|04.14.2017 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
| + | |||
| + | *[[Media:03_10_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|03.10.2017 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
| + | |||
| + | *[[Media:02_10_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary-esp.FINAL.pdf|02.10.2017 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
| + | |||
| + | *[[Media:01_20_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary-FINAL.pdf|01.20.2017 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
| + | |||
==2016== | ==2016== | ||
| + | |||
| + | *[[Media:11_11_2016_QIBA_Amyloid_Biomarker_Ctte_Call_Summary-FINAL.pdf|11.11.2016 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
| + | |||
| + | *[[Media:10_14_2016_QIBA_Amyloid_Biomarker_Ctte_Call_Summary-FINAL.pdf|10.14.2016 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
| + | |||
| + | *[[Media:09_09_2016_QIBA_Amyloid_Biomarker_Ctte_Call_Summary-DRAFT.pdf|09.09.2016 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
| + | |||
| + | *[[Media:08_12_2016_QIBA_Amyloid_Biomarker_Ctte_Call_Summary-FINAL.pdf|08.12.2016 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
| + | |||
*[[Media:07_08_2016_QIBA_Amyloid_Biomarker_Ctte_Call_Summary-FINAL.pdf|07.08.2016 QIBA PET Amyloid Biomarker Committee Call Summary]] | *[[Media:07_08_2016_QIBA_Amyloid_Biomarker_Ctte_Call_Summary-FINAL.pdf|07.08.2016 QIBA PET Amyloid Biomarker Committee Call Summary]] | ||
Latest revision as of 20:19, 11 September 2017
2017
- There are no notes for June, as this call was used for the Nuclear Medicine Coordinating Committee.
2016
2015
- 12.11.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 11.13.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 11.13.2015 QIBA PET Amyloid Biomarker Committee Meeting Slides
- 10.09.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 09.11.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 08.14.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 07.17.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 06.19.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 05.22.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 04.24.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 03.27.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 02.13.2015 QIBA PET Amyloid Biomarker Committee Call Summary
- 01.30.2015 QIBA PET Amyloid Biomarker Committee Call Summary